Environmental responsibility is becoming imperative; pharmaceutical companies face increasing demands to show that their logistics operations are both secure and sustainable. CSafe is excited to introduce its Silverskin RE reusable thermal cover, which effectively combines robust product protection with a significant reduction in waste and carbon emissions.
This reusable thermal cover is designed for durability and high performance throughout multiple uses. Constructed from robust, weather-resistant materials, it maintains thermal stability during various shipping cycles. Its exterior can be easily cleaned and sanitized, while a zip-closure door facilitates one-person operation, and integrated tracking provides transparency throughout complex logistics systems. The coverâs innovative tamper-evident design and adjustable straps enable compliance with both U.S. and EU pallet specifications, enhancing its versatility in global supply chains.
Connect with industry innovators at
F3: Future of Freight Festival, Oct 21-22.
Engage with top professionals and explore future trends.
The Silverskin RE is designed to manage temperature effectively in two critical ranges: +2 °C to +8 °C and +15 °C to +25 °C, accommodating a wide variety of pharmaceuticals from biologics to more stable formulations. Clients have the option to buy the units outright or utilize CSafeâs rental program, which includes comprehensive lifecycle management services such as inspection, cleaning, regulatory adherence, and return logistics.
âWe view sustainability as a fundamental aspect, not merely a desirable feature, in the design of next-generation cold chain logistics,â stated Patrick Schafer, CEO of CSafe. âWith the Silverskin RE, we offer pharmaceutical companies a viable alternative to single-use thermal coversâa solution that provides the reliability CSafe is known for while also decreasing waste, emissions, and long-term lifecycle expenses.â
The cold chain presents significant resource challenges, with cooling systems in logistics utilizing approximately 5% of the world’s total energy and representing about 2.5% of global greenhouse gas emissions, surpassing even the aviation sector. Notably, the pharmaceutical cold chain is particularly carbon-heavy: certain studies indicate it generates 55% more greenhouse gas emissions than the automotive industry. The global healthcare sector is responsible for roughly 4.4% of total greenhouse gas emissions, driven mainly by transportation, manufacturing, and packaging of medical products.
In addition to energy consumption and emissions, the problem of waste is significant. The biopharmaceutical industry is reported to produce approximately 300 million tons of plastic waste each year, primarily from single-use packaging. Unfortunately, over 90% of all packaging waste ultimately ends up in landfills or contributes to environmental pollution.
